AN2 Therapeutics (ANTX)

• Market cap: $172M
• 1 day: 2.14%
• 5 days: 0%
• 1 month: 41.84%
• 3 months: 350.94%
• 6 months: 319.3%
• Year to date: 330.63%
• 1 year: 298.33%
• 5 years: -68.96%
• 10 years: -68.96%
• Sector: Healthcare
• Industry: Biotechnology

About: AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology. Product candidate AN2-502998 Epetraborole.

Employees: 21